financetom
Business
financetom
/
Business
/
What's Going On With DraftKings Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With DraftKings Stock?
Jun 10, 2024 8:43 AM

DraftKings Inc ( DKNG ) shares are trading higher Monday. The company filed for a mixed shelf offering on Friday before being named a top pick by Morgan Stanley this week.

What To Know: After the market close on Friday, DraftKings ( DKNG ) filed a prospectus supplement for the proposed sale of up to 7.5 million shares of its Class A common stock by selling stockholders.

All of the shares being offered would be sold by the selling stockholders for their respective accounts. DraftKings ( DKNG ) will not receive any of the proceeds from the sales by the selling stockholders.

DraftKings ( DKNG ) shares traded lower following the filing, but the stock is bouncing back in early trading Monday. The upward momentum appears to be due to reports indicating DraftKings ( DKNG ) was added to Morgan Stanley’s Top Picks list on Monday.

Several reports suggest Morgan Stanley argued in a new note to clients that recent tax increase concerns could be overdone. The firm reportedly sees earnings upside on the horizon.

Morgan Stanley reiterated DraftKings ( DKNG ) with an Overweight rating and a price target of $51.

See Also: Caitlin Clark Not Selected For US Olympic Basketball Team Roster, WNBA Rookie Will Miss Paris

How To Buy DKNG Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in DraftKings' ( DKNG ) case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

DKNG Price Action: DraftKings ( DKNG ) shares were up 1.82% at $37.56 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Emeren Group Signs Seven-Year Power Purchase Agreement in Poland; Shares Up Pre-Bell
Emeren Group Signs Seven-Year Power Purchase Agreement in Poland; Shares Up Pre-Bell
Dec 30, 2024
07:15 AM EST, 12/30/2024 (MT Newswires) -- Emeren Group ( SOL ) said Monday it signed a seven-year power purchase agreement for a 15,000 MWh solar farm in Poland. Emeren ( SOL ) said the solar farm will supply energy under a pay-as-produced agreement to the Polish subsidiary of a multinational consumer goods business. Financial details of the agreement were...
Novartis Says Gene Therapy for Spinal Muscular Atrophy Meets Primary Endpoint in Phase 3 Study
Novartis Says Gene Therapy for Spinal Muscular Atrophy Meets Primary Endpoint in Phase 3 Study
Dec 30, 2024
07:12 AM EST, 12/30/2024 (MT Newswires) -- Novartis ( NVS ) said in a regulatory filing Monday that its phase 3 study evaluating its one-time gene therapy intrathecal onasemnogene abeparvovec, or OAV101 IT, met its primary endpoint. Based on the results, there was an increase from baseline in the Hammersmith Functional Motor Scale - Expanded, or HFMSE, total score in...
BRIEF-Wabtec Acquires Bloom Engineering To Strengthen Portfolio
BRIEF-Wabtec Acquires Bloom Engineering To Strengthen Portfolio
Dec 30, 2024
Dec 30 (Reuters) - Westinghouse Air Brake Technologies Corp ( WAB ): * WABTEC ACQUIRES BLOOM ENGINEERING TO STRENGTHEN ITS HEAT TRANSFER AND ENERGY SOLUTION PORTFOLIO * WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP ( WAB ) - WABTEC EXPECTS BLOOM TO BE IMMEDIATELY ACCRETIVE TO EPS * WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP ( WAB ) - WABTEC ACQUIRED BLOOM FOR $69...
BRIEF-Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
BRIEF-Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Dec 30, 2024
Dec 30 (Reuters) - Marinus Pharmaceuticals ( MRNS ): * IMMEDICA TO ACQUIRE BIOPHARMACEUTICAL COMPANY MARINUS PHARMACEUTICALS, INC. * MARINUS PHARMACEUTICALS INC ( MRNS ) - IMMEDICA TO ACQUIRE MARINUS FOR $0.55 PER SHARE Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved